Remove Communication Remove Information Remove Pharmaceutical Companies
article thumbnail

10 Innovative Trends in Pharma Marketing: Strategies for Industry Success in 2025

Pharma Marketing Network

Companies are investing heavily in digital tools to streamline communication and build stronger connections. Strategies like storytelling, personalized educational content, and two-way communication channels create trust and build loyalty. Patient-Centric Marketing Patients want to feel heard.

article thumbnail

Potential impact of Pharma Tariffs on Marketing

Pharma Marketing Network

Table of Contents: Understanding Pharma Tariffs Impacts on Branded Drug Marketing Adjusting Digital Advertising Strategies Strategic Recommendations for Pharma Marketers Conclusion FAQs Understanding Pharma Tariffs Pharma tariffs are taxes imposed by governments on imported pharmaceutical products. How do pharma tariffs impact drug pricing?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Changing the PAP Model

Pharmaceutical Commerce

Structuring patient assistance programs as independent non-profit foundations helps pharmaceutical companies reduce regulatory and legal exposure while allowing for more holistic, patient-centered support. Lastly, PAPs that are directly managed by pharmaceutical companies may also struggle with public image issues.

article thumbnail

Why 2025 Will Be a Breakout Year for Pharma Marketing Innovation

Pharma Marketing Network

Additionally, regulatory bodies like the FDA are encouraging patient-focused communications, further legitimizing this trend. The Inflation Reduction Act and new drug pricing regulations are pushing pharmaceutical companies to justify value more transparently. Optimizing content for voice queries will be a game-changer.

article thumbnail

CNS innovator oligonucleotide licensing value up 339% from £2bn in 2024

Pharmaceutical Technology

Large pharmaceutical companies such as AbbVie, Lilly, Roche and Takeda have demonstrated strong interest in licensing innovator oligonucleotides for CNS indications, accounting for 63% of licensing deals between 2021 and 2025 year-to-date. ASOs accounted for more than half ($3.54 billion), while siRNAs made up more than a third ($2.51

article thumbnail

The Importance of Modernizing Your Email Marketing Campaigns

Pharma Marketing Network

Email recipients want relevant and valuable information – not just promotional content. This ensures consistent communication without overburdening your team. In pharma, this also means balancing branded and unbranded messages carefully, especially when linking to product sites or prescribing information.

HIPAA 52
article thumbnail

AI in Medical Affairs: Revolutionizing Life Sciences with AI-Powered Tools

Viseven

Scientific communication : Drafting slide decks, scientific responses, medical information letters, and training content using generative models, ensuring scientific accuracy and compliance in messaging and content. Clinical trials One reason clinical trials fail is choosing the wrong patients.